ESC Premium Access

Antithrombotic strategies in coronary artery disease

Event: ESC CONGRESS 2017
Topic: Thrombosis and coagulation
Session type: Rapid Fire Abstracts
Date: 28 August 2017
Time: 08:30 - 10:00

Congress Session

10 presentations in this session

Antithrombotic treatment in patients with stable CAD and AF - 5-year follow-up data from the CLARIFY registry

Speaker: Doctor R. Wakili (Essen, DE)
Thumbnail

Application of DAPT score to predict ischaemic and bleeding events in patients who underwent drug-eluting stent implantation: a landmark analysis of large pooled cohort

Speaker: Doctor Y. Yoshikawa (Kyoto, JP)
Thumbnail

Growth differentiation factor 15 and bleeding risk with ticagrelor in patients with prior myocardial infarction: insights from PEGASUS-TIMI 54.

Speaker: Doctor M. Bonaca (Aurora, US)
Thumbnail

In-hospital switch of P2Y12 drugs in patients presenting with acute coronary syndrome: a meta-analysis of 14 observational and randomized studies including 10961 patients.

Speaker: Doctor M. Bianco (Orbassano, IT)
Thumbnail

Optimal long-term antithrombotic treatment of patients with stable coronary artery disease and atrial fibrillation: OLTAT registry

Speaker: Doctor Q. Fischer (Paris, FR)
Thumbnail

The effect of CYP2C19 gene polymorphism and clopidogrel dose on clinical outcomes in Asian populations with CAD receiving antiplatelet therapy.

Speaker: Mr W. Liu (Beijing, CN)
Thumbnail

Greater pharmacodynamic efficacy of ticagrelor compared to clopidogrel in patients with diabetes mellitus and stable coronary artery disease: a randomized investigation

Speaker: Doctor A. Marcano (L'Hospitalet de Llobregat, Barcelona, ES)
Thumbnail

Twice daily half-dosage aspirin intake promotes equal and perhaps even more platelet inhibition when compared to standard practice of once daily

Speaker: Miss J. Van Diemen (Amsterdam, NL)
Thumbnail

Glycemic variability assessed by continuous glucose monitoring and antiplatelet responsiveness in patients undergoing coronary stenting: results from the observational GLYVAR study

Speaker: Doctor A. Nusca (Rome, IT)
Thumbnail

Positive effect of new oral anticoagulation on coronary plaque composition? A coronary CT study

Speaker: Doctor F. Plank (Innsbruck, AT)
Thumbnail

10 speakers from this session

Doctor Reza Wakili

University of Duisburg-Essen - West-German Heart and Vascular Centre, Essen (Germany)
9 presentations
0 follower

Doctor Yusuke Yoshikawa

Kyoto University Graduate School of Medicine, Kyoto (Japan)
0 follower

Doctor Marc Bonaca

University of Colorado, Aurora (United States of America)
25 presentations
0 follower

Doctor Matteo Bianco

University Hospital San Luigi Gonzaga, Orbassano (Italy)
1 presentation
0 follower

Doctor Quentin Fischer

Hospital Bichat-Claude Bernard, Paris (France)
0 follower

Mr Wei Liu

Beijing Jishuitan Hospital, Beijing (China)
0 follower

Doctor Ana Marcano

IDIBELL, Bellvitge University Hospital, Heart Diseases Institute, L'Hospitalet de Llobregat, Barcelona (Spain)
0 follower

Miss Jeske Van Diemen

VU University Medical Center, Amsterdam (Netherlands (The))
0 follower

Doctor Annunziata Nusca

University Campus Bio-Medico of Rome, Rome (Italy)
0 follower

Doctor Fabian Plank

Innsbruck Medical University, Innsbruck (Austria)
0 follower

This platform is supported by

logo Novo Nordisk